Indefinite Delivery Contract SPE2DR25D2217

Award Date 9/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,999,999,999 IDC covers a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines,...
The subject Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 contract, running through December 2036, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical...
The Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, valued at $999,999,999, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a 30-month base period and three 30-month option periods, for a total estimated value of $30.3 billion. The IDC serves as the Pharmaceutical Prime Vendor Global...
The indefinite delivery contract (IDC) award, valued at $999,999,999, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp to provide pharmaceutical products and medical supplies in support of military healthcare programs globally. The contract has a base period of 30 months and three 30-month option periods, totaling an estimated $30.3 billion across all awards. The IDC serves as the primary vehicle for DLA Troop Support Medical to procure a comprehensive range of...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The single-award IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses a wide variety of critical medical...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at up to $999,999,999, is for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The period of performance runs through December 2025. The IDC serves as the primary vehicle for...
The Indefinite Delivery Contract (IDC) SPE2DR25D3802 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs,...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical products and medical supplies to the U.S. federal government. The IDC, valued at up to $999,999,999.00 through December 2025, serves as the primary vehicle for Amerisourcebergen to deliver essential medications, over-the-counter drugs, medical devices, and other...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 contract, with a period of performance through December 2036, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses...
The Indefinite Delivery Contract (IDC) SPE2DR25D7068 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers. The contract has a 30-month base period and three 30-month option periods, with a total estimated value of $999,999,999. The contract covers a comprehensive range of pharmaceutical products and...

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical and medical supply support to various DoD customers. The contract has a 30-month base period with three 30-month option periods, for a total estimated value of $999,999,999.

The IDC covers a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. It serves as a prime vehicle for supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries, enabling efficient government procurement of essential medical commodities. The contract is structured as a firm-fixed-price, requirements-type contract, with awards made on a regional basis to ensure resiliency and access to critical pharmaceuticals during contingencies or natural disasters.

Generated 6/6/25, 10:11 AM